Background With over 350,000 estimated deaths worldwide in 2018, prostate cancer (PCa)
continues to be a major health concern and a significant cause of cancer-associated …

Prostate cancer is a complex, progressive, bone-tropic disease, which is usually associated
with skeletal issues, poor mobility and a fatal outcome when it reaches the metastatic phase …

Background Easy access to palliative care is one of the basic needs of cancer patients, and
this can be achieved by providing such services at the community level. One approach to …

Prostate cancer is one of the most common cancer for men worldwide with advanced forms
showing supernumerary or clustered centrosomes. Hematological and neurological …

In the United States, racial differences in disease outcomes are well established.
Historically, research has focused on genetic and biological drivers, largely ignoring social …

Prostate cancer is one of the most common cancers in men. This study was conducted to
investigate the role of euchromatic histone lysine methyltransferase 2 (EHMT2) and …

Background Allopurinol is gout medication that inhibits uric acid formation. Its possible anti-
carcinogenic properties have been under research in past years. Studies based on …

HLA is critical in a variety of diseases, including infectious disease and cancer, and has
been used for diagnostic differentiation and immunosurveillance of certain diseases. In …

Prostate cancer (PrCa) is one of the most common cancers in men, but little is known about
factors affecting its clinical outcomes. Genome-wide association studies have identified …

Objective This systematic study aimed to assess and compare the comprehensive evidence
regarding the impact of neoadjuvant hormone therapy (NHT) on surgical and oncological …